Početna › Difuzna skleroderma › Pennsylvania
Kliničke studije za Difuzna skleroderma u državi Pennsylvania
6 studija za Difuzna skleroderma traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- EncompaSSc site in Philadelphia, PA, Philadelphia
- EncompaSSc site in Pittsburgh, PA, Pittsburgh
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT07287670A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
U tijeku regrutacijaFaza 2
Od 8 do 60 godina · Oba spola · Ažurirano 14. kol 2026. · NCT03630211The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 8. sij 2026. · NCT06675344Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.